New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 17, 2014
16:27 EDTGWPH, ORCL, CBI, MCRS, ACOR, SCTYOn The Fly: Closing Wrap
Stocks on Wall Street began the day in negative territory, thanks in part to worse than expected economic data. The consumer price index came in higher than expected, while housing starts and building permits both came in well below analysts' consensus forecasts. The averages drifted off their opening lows and eventually made it into positive territory, where the market drifted for most of the rest of the day. The volume was light, as investors sat on the sidelines while the Federal Reserve board convened for the central bank's latest rate setting and policy meeting. ECONOMIC EVENTS: In the U.S., the consumer price index rose 0.4% in May, which was above the consensus forecast for an increase of 0.2%. Housing starts in the month declined 6.5% to a rate of about 1M and building permits slid 6.4% to a rate of 991K, which were both lower than expected. The Federal Reserve began its latest Federal Open Market Committee meeting, which will conclude tomorrow. COMPANY NEWS: Elon Musk's SolarCity (SCTY) advanced $9.65, or 17.58%, to $64.53 after the solar energy system installer agreed to acquire solar panel technology and manufacturing company Silevo for up to $350M dollars. SolarCity said it sees its manufacturing capacity allowing it to create "the most vertically integrated solar company" with an "industry-leading" cost structure that aims to make solar competitive with grid costs. The company also said it is in talks with the state of New York to build a plant with targeted capacity greater than 1 GW within the next two years, which it says will be "one of the single largest solar panel production plants in the world." MAJOR MOVERS: Among the notable gainers was register system and hospitality software maker Micros Systems (MCRS), which surged $8.62, or 14.94%, to $66.33 after Bloomberg reported that the company is in talks to be acquired by tech giant Oracle (ORCL) for "more than" $5B. Also higher was GW Pharmaceuticals (GWPH), which jumped $12.57, or 16.27%, to $89.82 after it announced physician reports of efficacy and safety data on 27 children and young adults with treatment-resistant epilepsy who have been treated with GW's investigational cannabidiol product candidate, Epidiolex, for a period of 12 weeks. Among the noteworthy losers was Chicago Bridge & Iron (CBI), which fell $5.32, or 7.23%, to $68.26 after research firm Prescience Point alleged that the company has used "creative acquisition accounting" to conceal its losses and placed a Strong Sell rating on the shares. Also lower were shares of Acorda Therapeutics (ACOR), which fell $3.16, or 8.96%, to $32.12 after announcing an offering of $300M of convertible senior notes. INDEXES: The Dow was up 27.48, or 0.16%, to 16,808.49, the Nasdaq was up 16.13, or 0.37%, to 4,337.23, and the S&P 500 was up 4.21, or 0.22%, to 1,941.99.
News For MCRS;ORCL;SCTY;CBI;GWPH;ACOR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 16, 2015
15:44 EDTORCLCSC holding 'loose' deal talks, not running formal process, dealReporter says
Subscribe for More Information
11:03 EDTSCTYSolarCity initiated with an Outperform at Avondale
Subscribe for More Information
April 15, 2015
12:14 EDTSCTYSolarCity active call on renewed takeover speculation
SolarCity April 56.5 and 57 calls are active on total call volume of 4K contracts (1K puts) on renewed takeover speculation. April call option implied volatility is at 45, May is at 52, July is at 42, October is at 37; compared to its 26-week average of 49 according to Track Data. Active call volume suggests traders taking positions for large near term price movement.
12:05 EDTSCTYRumor: SolarCity active on renewed takeover speculation
Shares of SolarCity (SCTY) are moving higher amid speculation Mitsubishi Electric may acquire the company.
April 14, 2015
08:38 EDTGWPHGW Pharmaceuticals price target raised to $120 from $102 at Leerink
Leerink analyst Paul Matteis raised his price target for shares of GW Pharmaceuticals to $120 after the American Academy of Neurology disclosed updated Epidiolex data from 137 patients. Matteis calls the data better than expectations saying they showed a "much greater" magnitude of overall seizure reduction than in the October update and a "consistent, robust effect" in larger samples of Dravet and Lennox Gastaut patients. He now assumes higher Epidiolex peak market penetrations and more use in the broader refractory pediatric epilepsy population. The analyst reiterates an Outperform rating on GW Pharmaceuticals. The stock closed yesterday at $96.18 and is trading up $7.87 to $104.05 in premarket trading.
07:25 EDTGWPHGW Pharmaceuticals undervalued based on Epidiolex potential, says Cowen
Subscribe for More Information
April 13, 2015
16:09 EDTGWPHGW Pharmaceuticals notes new Epidiolex data released by AAN
GW Pharmaceuticals noted that the American Academy of Neurology, or AAN, issued a press release today on GW's investigational medicine, Epidiolex. Data in the AAN release are from physician-led FDA authorized Epidiolex "expanded access" programs for children and young adults with treatment-resistant epilepsy that have exhausted available treatment options. The data provide treatment effect information on a total of 137 patients who have at least 12 weeks of Epidiolex exposure. Safety data is provided on 213 patients, representing these 137 patients plus additional patients still in their first 12 weeks of treatment. Additional data will be presented in a poster at the AAN Annual Meeting on 22 April at 6.15pm EDT, at which time GW will make an additional disclosure.
12:42 EDTORCLFly Watch: Wells says ServiceNow likely to unveil upbeat revenue target
Subscribe for More Information
08:14 EDTSCTYSolarCity announces partnership with Nest Labs
Subscribe for More Information
April 10, 2015
08:23 EDTORCLOracle management to meet with Barclays
Subscribe for More Information
April 9, 2015
08:16 EDTSCTYBofA/Merrill sees catalysts ahead for SolarCity
Subscribe for More Information
05:57 EDTORCLOracle plans to hire 300 in India, Economic Times reports
Oracle is planning to hire 300 people in India to create a specialized cloud force, according to The Economic Times. Reference Link
April 7, 2015
10:10 EDTACORJazz patent on Xyrem latest to be challenged by Kyle Bass
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use